Bio News
A technology has been developed that can prevent deadly influenza with a single injection by genetically editing just dozens of hematopoietic stem cells to continuously produce protective antibodies. The technology uses CRISPR gene editing to directly insert a rare protective antibody gene into hematopoietic stem cells, which then generate antibody-producing B cells after transplantation. The research team plans to confirm the technology’s potential applications in a range of diseases, including HIV and genetic disorders, and proceed to studies in nonhuman primates.
BIOBOOK TEAM
biobookmedia@biobook.co.krMerck’s $1.3 trillion eye disease drug raises safety and efficacy concerns: “Limited competitiveness”
CHA Biotech Holds 24.23% Stake in CMG Pharmaceutical as Share Consolidation Reduces Its Share Count
Rural Development Administration Develops Two Molecular Markers to Identify Leaf Splitting in Squash
MFDS Begins Distribution of Internationally Certified Reference Materials, Including 24 New Items, for a Total of 882
Ministry of Trade, Industry and Energy signs agreement to promote biotech and medical devices in Gangwon; site visit set for the 14th
RDA develops technology to produce anti-inflammatory exosomes for pets and files patent application
Merck’s $1.3 trillion eye disease drug raises safety and efficacy concerns: “Limited competitiveness”
CHA Biotech Holds 24.23% Stake in CMG Pharmaceutical as Share Consolidation Reduces Its Share Count
Rural Development Administration Develops Two Molecular Markers to Identify Leaf Splitting in Squash
